Knowledgebase

Field LAB Lutetium 177

Medical isotope offers great perspective for the effective treatment of various cancer indications with limited side effects

Thumbnail Presentatie James Collection Item

During the Targeted Radiopharmaceuticals Summit, James Nagarajah gave a presentation. In his presentation he spoke about the challenges that can be faced during the development of a new radio pharmaceutical, and how these can be overcome by collaborating with suppliers, industry partners and medical institutes.

CISSPECT DESK LAB Proefstudie

For the past few months, pharmacist Jeske Hendriksen has been working as a PhD student in the Antoni van Leeuwenhoek hospital, where she is conducting research into radioactive cisplatin in the CISSPECT project. In this project, she is working alongside technical physician Else Aalbersberg, who has been at the Antoni van Leeuwenhoek for 8 years and involved in the CISSPECT project since the start.

Petten starts production xenon  3496 xs

Thanks to intensive collaboration between Curium and NRG, a complex project has been brought to a successful conclusion: the development and installation of a production process for the medical isotope Xenon-133.

Fieldlab Employe Development New Nuclear Medicines

FIELD-LAB is the incubator for new nuclear medicines. Together with partners FIELD-LAB develops new nuclear medicine for personalised treatment of cancer patients.

Konijnenberg Op Congres NRG

Despite many innovative developments in nuclear medicine, bringing the nuclear end product to the physician and thus the patient, remains a long-term and (therefore) often frustrating mission. Hopefully, this will not be the case any longer, according to physicist dr. Mark Konijnenberg of the department Radiology and Nuclear Medicine, Erasmus MC in Rotterdam.

Reactor

Every day, 30.000 patients benefit from medical isotopes from Petten. The NRG reactor, where the medical isotopes are irradiated, changed its fuel to low-enriched uranium in 2006.

James Nagarajah NRG

As Prof. Dr. James Nagarajah, assistant professor Nuclear Medicine at Radboud University in Nijmegen addressed during his talk PSMA Guided Theranostics in Prostate Cancer at NRG at February 1, 2019, the future of prostate cancer (PCa) may be rather exciting.

Sanderdegroot

The plans for FIELD-LAB in Petten are really starting to take shape and there are lots of people who can't wait to contribute to this special initiative.

Development Of New Nuclear Medicines

The official launch of FIELD-LAB took place on February 6, 2019 in Petten. A unique collaboration to benefit a wide range of patients.